Skip to Main Content

Rigel Pharmaceuticals

Rigel Pharmaceuticals develops innovative therapies for hematologic disorders and cancers, including TAVALISSE®, REZLIDHIA®, and GAVRETO®.

Rigel-Pharmaceuticals Homepage 1440px